Mesothelioma stages
Understanding mesothelioma staging
The stage of mesothelioma refers to its size and the thickness of the pleura. The stage also tells you if the cancer has spread to the lymph nodes, and beyond the area of the body where it first started. Knowing the stage of the cancer helps you and your doctors decide on the best treatment for you.
There are different staging systems. Many are based on the TNM system:
- T describes the size of the cancer.
- N describes whether the cancer has spread to the lymph nodes and which nodes are involved. For example, N0 means that no lymph nodes are affected, while N1 means there are cancer cells in the lymph nodes.
- M describes whether the cancer has spread (metastasised) to another part of the body. For example, M0 means the cancer has not spread to other parts of the body, while M1 means the cancer has spread to other parts of the body.
We understand that waiting to know the stage and grade of your cancer can be a worrying time. We're here if you need someone to talk to. You can:
- call the Macmillan Support Line on 0808 808 00 00
- chat to our specialists online.
- visit our mesothelioma forum to talk with people who have been affected by mesothelioma, share your experience, and ask an expert your questions.
Related pages
Staging of pleural mesothelioma
The staging system that is often used for pleural mesothelioma is written by the International Association for the Study of Lung Cancer (IASLC). It is based on the TNM system.
Stage 1
The cancer is limited to the pleura, in one side of the chest. It is 12mm or less in thickness. The cancer has not spread to the lymph nodes.
Stage 2
The cancer is the same as stage 1 but has also spread to nearby lymph nodes (N1).
Or the cancer is 12mm thick or less and has grown into the tissue beneath the pleura. The cancer has not spread to the lymph nodes.
Or the cancer is more than 12mm thick but less than 30mm and may or may not have spread into the tissue beneath the pleura. It has not spread to the lymph nodes.
Stage 3
Stage 3 pleural mesothelioma is divided into Stage 3a and Stage 3b.
Stage 3a
- The cancer is up to 12mm thick and has spread to lymph nodes on the other side of the chest (N2).
- Or the cancer is between 12mm and 30mm thick and may also have spread into the tissue beneath the pleura. It has also spread to lymph nodes nearby (N1) or further away (N2).
- Or the cancer is 30mm or more and involving tissue beneath the pleura. It may or may not have spread to lymph nodes nearby (N1) or further away (N2).
Stage 3b
The cancer is any thickness and has spread further into the chest wall.
- It may have affected, for example, the ribs, oesophagus or windpipe (trachea).
- It may also have spread through the lining of the heart, or through the diaphragm.
- It may or may not have spread to nearby lymph nodes, or lymph nodes further away on the other lung.
Stage 4
The cancer has spread outside of the chest to another area of the body (metastasis or M1).
Staging of peritoneal mesothelioma
There is no specific staging system for peritoneal mesothelioma. But your cancer team may sometimes use the Peritoneal Cancer Index (PCI) system.
This looks at:
- the number of tumours in the peritoneum
- the size of the tumours
- where the tumours are in the tummy area (abdomen)
- whether the cancer has spread outside the peritoneum or to any lymph nodes.
PCI is only used in specialist centres. You can ask your cancer doctors for more information if you have any questions.
About our information
This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer.
-
References
Below is a sample of the sources used in our mesothelioma cancer information. If you would like more information about the sources we use, please contact us at informationproductionteam@macmillan.org.uk
Kusamura S, Kepenekian V, Villeneuve L, Lurvink RJ, Govaerts K, De Hingh IHJT, Moran BJ, Van der Speeten K, Deraco M, Glehen O; PSOGI. Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2021 Vol, 47(1) pp6-59. [accessed April 2024].
Popat, S., Baas P., Faivre-Finn, C., Girard, N., Nicholson, A., Nowak, A., Opitz, I., Scherpereel, A, and Reck, M. 2021. ESMO Pleural mesothelioma guidelines. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Available from: https://www.annalsofoncology.org/action/showPdf [accessed April 2024].
Date reviewed

Our cancer information meets the PIF TICK quality mark.
This means it is easy to use, up-to-date and based on the latest evidence. Learn more about how we produce our information.
The language we use
We want everyone affected by cancer to feel our information is written for them.
We want our information to be as clear as possible. To do this, we try to:
- use plain English
- explain medical words
- use short sentences
- use illustrations to explain text
- structure the information clearly
- make sure important points are clear.
We use gender-inclusive language and talk to our readers as ‘you’ so that everyone feels included. Where clinically necessary we use the terms ‘men’ and ‘women’ or ‘male’ and ‘female’. For example, we do so when talking about parts of the body or mentioning statistics or research about who is affected.
You can read more about how we produce our information here.
